The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in mice

By afschroeder • October 25, 2025

In Het Panhuis W, Thiemann E, van Dijk DMAH, Been B, Jarrett KE, Meurs A, Kooijman S, Hovingh MV, Modder M, van Os BW, Sluiter TJ, Blomberg N, Pronk ACM, Afkir S, Streefland TCM, Lalai RA, Taveras MO, Zhang S, Adams TE, Terry LV, Turpin-Nolan SM, de Vries MR, Giera M, Rose-John S, Zelcer N, de Boer JF, de Aguiar Vallim TQ, Febbraio MA, Rensen PCN, Schönke M. The designer cytokine IC7Fc attenuates atherosclerosis development by targeting hyperlipidemia in mice. Sci Adv. 2025 Oct 24;11(43):eadx3794. doi: 10.1126/sciadv.adx3794. Epub 2025 Oct 24. PMID: 41134879; PMCID: PMC12551718.

Tags: Cardiology/Epi, Publications

Association Between Colchicine Use and Clinical Outcomes Post Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials

Jaiswal V, Hanif M, Raja HAA, Khadka S, Deb N, Mashkoor Y, Ahmed A, Rajak K, Jaiswal AK, Gupta M, Hirji S, Fonarow GC, Qamar[...]

A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes

Dorsch MP, Gilotra NA, Spaulding EM, Martin SS, Zhao H, Wilson GA, Poddar M, Verma A, Schmiedmayer P, Kraft P, Rodriguez F, Azizi Z, Hwang[...]

Digital Health Intervention to Optimize Heart Failure Management After Hospital Discharge in Brazil (OPT-HF): A Randomized Clinical Trial

Ciminelli ALA, Sandhu AT, Longenecker CT, Rezende LC, Camelo LV, Gonçalves BPA, Lino RZS, Bramucci V, Melo BMH, Siqueira CV, Carvalho APV, Ribeiro EG, Ferreira[...]